Shahrokh Ganjian

DDS | Dentist



  
  9737 63rd Dr, Ste 1k, Rego Park
  New York, 11374-2229

  718-897-8900    718-897-6363 Maps & Directions
Shahrokh Ganjian is a Rego Park, New York based Dentist who is specialized in Dentistry. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 9737 63rd Dr, Ste 1k, Rego Park. Patients can reach him at 718-897-8900.
Shahrokh Ganjian is the primary dental care provider for patients of all ages. He is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Shahrokh Ganjian speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Shahrokh Ganjian
Specialization: Dentist
Gender:Male
Credentials: DDS
Accepts Medicare Assignment:May Accept
Practice Address:9737 63rd Dr, Ste 1k, Rego Park,
New York, 11374-2229
Phone:718-897-8900
Fax:718-897-6363
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 4284735473
Enrollment ID: I20160421001910
NPI Number: 1427049907
NPI Enumeration Date: 02 Nov, 2005
NPI Last Update On: 08 Jul, 2007

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 9737 63rd Dr, Ste 1k
Rego Park, New York
Zip: 11374-2229
Phone Number: 718-897-8900
Fax Number: 718-897-6363
Patients can reach Shahrokh Ganjian at 9737 63rd Dr, Ste 1k, Rego Park, New York or can call to book an appointment on 718-897-8900. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 May, 2024.

Comments/ Reviews: